Stoke Therapeutics (STOK) EV to CFO (2025)
Stoke Therapeutics' (STOK) EV to CFO stood at 34.78 in Q4 2025, up 75.6% from the prior quarter.
Powered by 
Analysis
Stoke Therapeutics (STOK) EV to CFO (2025) Analysis & Trends
Starting with Q1 2025, Stoke Therapeutics' EV to CFO history includes 4 quarters.
- Per Business Quant, the preceding three quarters came in at 19.81 (Q3 2025), 6.06 (Q2 2025) and 0.08 (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Stoke Therapeutics | 1.70 Bn | 529.30 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 34.78 |
| Sep 30, 2025 | 19.81 |
| Jun 30, 2025 | 6.06 |
| Mar 31, 2025 | 0.08 |
API Access
Stoke Therapeutics EV to CFO API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=STOK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-cfo", "ticker": "STOK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=STOK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();